TDOC Relative Valuation
TDOC's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, TDOC is overvalued; if below, it's undervalued.
Historical Valuation
Teladoc Health Inc (TDOC) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of -32.73. The fair price of Teladoc Health Inc (TDOC) is between NaN to NaN according to relative valuation methord.
Relative Value
Fair Zone
NaN-NaN
Current Price：7.78
Fair
-8.48
PE
1Y
3Y
5Y
Trailing
Forward
5.65
EV/EBITDA
Teladoc Health Inc. (TDOC) has a current EV/EBITDA of 5.65. The 5-year average EV/EBITDA is 31.02. The thresholds are as follows: Strongly Undervalued below -41.19, Undervalued between -41.19 and -5.09, Fairly Valued between 67.12 and -5.09, Overvalued between 67.12 and 103.23, and Strongly Overvalued above 103.23. The current Forward EV/EBITDA of 5.65 falls within the Historic Trend Line -Fairly Valued range.
-10.32
EV/EBIT
Teladoc Health Inc. (TDOC) has a current EV/EBIT of -10.32. The 5-year average EV/EBIT is -60.33. The thresholds are as follows: Strongly Undervalued below -561.82, Undervalued between -561.82 and -311.07, Fairly Valued between 190.41 and -311.07, Overvalued between 190.41 and 441.15, and Strongly Overvalued above 441.15. The current Forward EV/EBIT of -10.32 falls within the Historic Trend Line -Fairly Valued range.
0.53
PS
Teladoc Health Inc. (TDOC) has a current PS of 0.53. The 5-year average PS is 3.69. The thresholds are as follows: Strongly Undervalued below -5.78, Undervalued between -5.78 and -1.05, Fairly Valued between 8.42 and -1.05, Overvalued between 8.42 and 13.15, and Strongly Overvalued above 13.15. The current Forward PS of 0.53 falls within the Historic Trend Line -Fairly Valued range.
4.40
P/OCF
Teladoc Health Inc. (TDOC) has a current P/OCF of 4.40. The 5-year average P/OCF is 39.49. The thresholds are as follows: Strongly Undervalued below -69.01, Undervalued between -69.01 and -14.76, Fairly Valued between 93.74 and -14.76, Overvalued between 93.74 and 148.00, and Strongly Overvalued above 148.00. The current Forward P/OCF of 4.40 falls within the Historic Trend Line -Fairly Valued range.
6.63
P/FCF
Teladoc Health Inc. (TDOC) has a current P/FCF of 6.63. The 5-year average P/FCF is 63.30. The thresholds are as follows: Strongly Undervalued below -120.53, Undervalued between -120.53 and -28.62, Fairly Valued between 155.22 and -28.62, Overvalued between 155.22 and 247.14, and Strongly Overvalued above 247.14. The current Forward P/FCF of 6.63 falls within the Historic Trend Line -Fairly Valued range.
Teladoc Health Inc (TDOC) has a current Price-to-Book (P/B) ratio of 0.99. Compared to its 3-year average P/B ratio of 1.24 , the current P/B ratio is approximately -20.12% higher. Relative to its 5-year average P/B ratio of 1.32, the current P/B ratio is about -24.98% higher. Teladoc Health Inc (TDOC) has a Forward Free Cash Flow (FCF) yield of approximately 0.00%. Compared to its 3-year average FCF yield of 14.35%, the current FCF yield is approximately -100.00% lower. Relative to its 5-year average FCF yield of 9.10% , the current FCF yield is about -100.00% lower.
0.99
P/B
Median3y
1.24
Median5y
1.32
20.96
FCF Yield
Median3y
14.35
Median5y
9.10
Competitors Valuation Multiple
The average P/S ratio for TDOC's competitors is , providing a benchmark for relative valuation. Teladoc Health Inc Corp (TDOC) exhibits a P/S ratio of , which is NaN% above the industry average. Given its robust revenue growth of -2.20%, this premium appears unsustainable.
P/S
P/E
EV/EBITDA
EV/EBIT
P/S
Revenue Growth
Market Cap
Performance Decomposition
1Y
3Y
5Y
Market capitalization of TDOC decreased by 14.41% over the past 1 year. The primary factor behind the change was an decrease in Margin Expansion from -5.20 to -7.90.
The secondary factor is the Revenue Growth, contributed -2.20%to the performance.
Overall, the performance of TDOC in the past 1 year is driven by Margin Expansion. Which is more sustainable.
People Also Watch
FAQ
Is Teladoc Health Inc (TDOC) currently overvalued or undervalued?
What is Teladoc Health Inc (TDOC) fair value?
How does TDOC's valuation metrics compare to the industry average?
What is the current P/B ratio for Teladoc Health Inc (TDOC) as of Dec 05 2025?
What is the current FCF Yield for Teladoc Health Inc (TDOC) as of Dec 05 2025?
What is the current Forward P/E ratio for Teladoc Health Inc (TDOC) as of Dec 05 2025?